Nilotinib 200 mg Capsules

Get a Price/Quote

MOQ : 100 Packs

Nilotinib 200 mg Capsules Specification

Dosage Form
Capsules

Indication
Chronic Myeloid Leukemia (CML)

Salt Composition
Nilotinib (200 mg)

Feature
Oral formulation for targeted leukemia treatment

Ingredients
Nilotinib hydrochloride monohydrate, inactive ingredients

Application
Anticancer therapy

Physical Color/Texture
Off-white to light yellow capsules

Fermentation Smell
Odorless or nearly odorless

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 months

Standard of Quality
Complies with pharmacopeial standards

Common Side Effects
Rash, nausea, pruritus, headache, fatigue

Drug Class
Tyrosine kinase inhibitor

Prescription Required
Yes

Packaging Type
Blister pack or bottle

Strength
200 mg per capsule

ATC Code
L01XE08

Route of Administration
Oral

Nilotinib 200 mg Capsules Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Nilotinib 200 mg Capsules

Nilotinib 200 mg Capsules are highly recommended for patients seeking peerless and targeted therapy for Chronic Myeloid Leukemia (CML). Favored by healthcare professionals and supported by outstanding, favorable reviews, these pristine capsules comply with rigorous pharmacopeial standards. Featuring a potent 200 mg strength per capsule and delivered via an oral route, Nilotinib ensures optimal efficacy and patient convenience. Supplied in secure blister packs or bottles, each sale includes medication manufactured in India by trusted suppliers and traders. Prescription is required for purchase. Experience quality and reliability you can trust.

Applications & Usage of Nilotinib 200 mg Capsules

Nilotinib 200 mg Capsules are primarily applied in the field of oncology, specifically for the treatment of Chronic Myeloid Leukemia (CML). Administered orally, these capsules are intended for use on the internal surface of the gastrointestinal tract, ensuring a direct and efficient route for anticancer therapy. Used under doctor supervision, they are suited for adults requiring targeted intervention, offering a specialized regimen as part of long-term cancer management.

Packaging & Shipping Details of Nilotinib Capsules

Nilotinib 200 mg Capsules are available in pristine blister packs or carefully sealed bottles to preserve their outstanding quality. Each order is shipped via reliable drop-off and shipping services to ensure prompt delivery. FOB ports in India facilitate international supply, and sample capsules can be estimated and shipped for evaluation upon request. With a shelf life of 24 months, all packages are designed to maintain product freshness and integrity throughout transit.

FAQ's of Nilotinib 200 mg Capsules:

Q: How should Nilotinib 200 mg Capsules be stored for optimal quality?

A: Nilotinib capsules should be stored below 30C, protected from moisture, and kept in their original blister pack or bottle to maintain their pristine and peerless quality.

Q: What is the primary indication for using Nilotinib 200 mg Capsules?

A: These capsules are indicated for the treatment of Chronic Myeloid Leukemia (CML) as part of advanced anticancer therapy, under medical supervision.

Q: When should patients take Nilotinib 200 mg Capsules during their treatment?

A: Patients should follow their doctor's guidance regarding the exact timing and dosage, as Nilotinib is typically taken orally at evenly spaced intervals.

Q: Where can Nilotinib 200 mg Capsules be sourced or shipped from?

A: Supplied and shipped by trusted Indian traders and suppliers, Nilotinib capsules can be dispatched internationally via FOB ports using reliable shipping and drop-off services.

Q: What is the process to obtain Nilotinib 200 mg Capsules?

A: A valid prescription is required. Once obtained, the capsules can be ordered through authorized suppliers or traders, who will estimate delivery and shipping details.

Q: How does the oral usage of Nilotinib benefit cancer patients?

A: Oral administration offers patients a convenient, non-invasive method for targeted therapy, enhancing adherence and improving ongoing cancer management.

Tell us about your requirement